Cartesian Therapeutics, Inc. (RNAC)
6.68
+0.16
(+2.45%)
USD |
NASDAQ |
May 21, 16:00
6.715
+0.04
(+0.52%)
After-Hours: 19:59
Cartesian Therapeutics Research and Development Expense (TTM) : 62.82M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 828.00M |
| Regeneron Pharmaceuticals, Inc. | 5.526B |
| Precision BioSciences, Inc. | 52.46M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |